Persistent placoid maculopathy is a rare inflammatory eye condition that affects the back of the eye and can blur central vision. Early symptoms of persistent placoid maculopathy often include a dark spot, hazy vision, trouble reading, or colors seeming less clear, sometimes in one eye first. It is most often recognized in adults, and the course can last for months or longer with relapses in some people. Not everyone will have the same experience. Persistent placoid maculopathy is not usually life-threatening, and treatment often involves prompt care from an eye specialist with corticosteroids or other medicines that calm inflammation.
How many people live with Persistent placoid maculopathy?
Persistent placoid maculopathy is a very rare eye condition, but no trustworthy estimate is available for how many people live with it worldwide or in the United States. Published reports describe only small numbers of people rather than population-wide counts, so major health sources do not appear to report a reliable global or U.S. total.
Overview
Persistent placoid maculopathySymptoms
Persistent placoid maculopathy often causes blurry or dim central vision, blind spots, and trouble reading or seeing fine detail. Some people also notice distorted vision or colors seeming less clear in one or both eyes.
Outlook and prognosis
Persistent placoid maculopathy can cause lasting blurry or patchy central vision, especially if both eyes are affected. Some people stabilize after the active phase, but others have permanent blind spots. Close follow-up matters because relapses and new retinal damage can occur.
Causes and risk factors
Persistent placoid maculopathy is rare, and its exact cause is still unclear. Current evidence points to reduced blood flow and inflammation in the back of the eye; no specific lifestyle or inherited risk factors have been confirmed.
Genetic influences
Genetics do not appear to play a major role in Persistent placoid maculopathy. Most cases are not thought to be inherited, and no specific gene changes are known to clearly cause it.
Diagnosis
Persistent placoid maculopathy is diagnosed with an eye exam and retinal imaging, often including optical coherence tomography, fluorescein angiography, and fundus photos. Doctors may also order blood tests to rule out infections or inflammatory causes.
Treatment and drugs
Treatment for persistent placoid maculopathy usually focuses on calming inflammation quickly to help protect central vision. Many living with persistent placoid maculopathy are treated with corticosteroids, and some also need longer-term immune-suppressing medicines. Close follow-up with a retina specialist and repeat eye imaging are important.
Symptoms
Persistent placoid maculopathy usually shows up as painless changes in central vision, often in one eye first but sometimes in both. In everyday life, this can mean a blurry or washed-out patch right where you try to focus, making reading, driving, or seeing faces more difficult. Early symptoms of Persistent placoid maculopathy can be subtle at first, then become more noticeable over days or weeks. Symptoms vary from person to person and can change over time.
Central vision often becomes hazy or out of focus, even if side vision seems less affected. Small print, phone screens, and facial details may suddenly be harder to make out.
Some people notice a dark, gray, or missing area near the center of what they see. This can make words seem to disappear while reading or leave part of a face harder to see.
Straight lines can look bent, warped, or uneven. Text lines, door frames, or road markings may seem distorted instead of crisp.
Colors may look less vivid, and contrast can seem washed out. With Persistent placoid maculopathy, this may be most obvious in dim light or when trying to tell similar shades apart.
How people usually first notice Persistent placoid maculopathy?
People usually first notice persistent placoid maculopathy when vision changes rather suddenly, often as a blurry or dim patch near the center of sight in one eye, though both eyes can be affected. Some also describe faded colors, trouble reading, or a small blind spot that makes faces or fine detail harder to see, while the eye itself may not look red or feel very painful. Because these first warning signs can mimic other retinal problems, new central vision loss or distortion should be checked by an eye specialist quickly.
Types of Persistent placoid maculopathy
Persistent placoid maculopathy can affect day-to-day vision in slightly different ways, even though it is considered one eye condition. In practice, doctors do not divide it into many formal types of persistent placoid maculopathy, but the symptom pattern can differ depending on whether one or both eyes are involved and how much the center of vision is affected. Symptoms don’t always look the same for everyone.
One-eye pattern
Some people first notice changes in just one eye, such as blur, a dim spot, or trouble reading with that eye. This can be easy to miss at first because the other eye may still see well.
Both-eye pattern
Many living with persistent placoid maculopathy may develop symptoms in both eyes, either at the same time or one after the other. When this happens, reading, driving, and seeing fine detail can become much harder.
Central vision loss
A common symptom pattern is blurred or washed-out vision in the center, where sharp detail is needed most. You might notice faces seem less clear or words look smudged even in good light.
Blind spot pattern
Some may find they have a dark, gray, or missing patch in their vision, also called a scotoma. This can make straight-ahead tasks frustrating, while side vision may feel less affected.
Mild early symptoms
Early symptoms of persistent placoid maculopathy can be subtle, such as slight haze, reduced contrast, or colors looking less vivid. For many, this can mean vision feels off before there is major loss of detail.
Can I slow down the onset of symptoms?
Probably not: for persistent placoid maculopathy, a rare eye condition, there is no strong evidence that lifestyle changes or medicines can meaningfully delay the first symptoms. Research has not shown that diet, exercise, supplements, or other daily habits reduce the risk in a reliable way, and there is no proven screening or preventive treatment to stop it before it starts. The most helpful step is to get prompt eye care if new blurry vision or dark spots appear, because early treatment may help limit damage even though it cannot be counted on to prevent the condition.
What genetics can tell you about symptoms
At this time, genetics does not appear to play a clear, well-established role in persistent placoid maculopathy, and there is no known gene change that reliably predicts who will develop it. In other words, genetic testing is not usually able to tell whether symptoms will start earlier, affect vision more severely, or follow a certain pattern. For most people living with this condition, symptoms and their course are guided more by the eye inflammation itself and the underlying cause, if one is found, than by inherited genetic differences.
Causes and risk factors
The exact causes of persistent placoid maculopathy are still unclear. Most experts think it involves inflammation and reduced blood flow in the tissue under the retina. In some people, a recent infection or another immune trigger may play a part, but this link is not firmly proven. Researchers are still learning how these pieces fit together. No clear inherited gene change or lifestyle habit has been shown to cause persistent placoid maculopathy, and most people who develop it did nothing to bring it on.
What are the most common causes or risk factors?
The exact cause of persistent placoid maculopathy is still unclear, but it is most likely linked to inflammation that reduces blood flow in the thin layer of vessels that feeds the retina, the light-sensing tissue at the back of the eye. There is no known inherited or genetic cause, and most people who get it do not have a clear family history or an obvious trigger. Because it is very rare, firm risk factors are not well defined, but it has been reported most often in adults, sometimes after an illness that may have stirred up the immune system.
Environmental and biological risk factors
Persistent placoid maculopathy is a rare eye condition that can blur the sharp central vision used for reading, recognizing faces, and driving. Because the causes of persistent placoid maculopathy are still being studied, its risk factors are not as clearly mapped out as they are for more common eye diseases. Doctors often group risks into internal (biological) and external (environmental), and for this condition the stronger clues so far are mainly biological.
Persistent placoid maculopathy has mainly been reported in adults rather than in children. Adult age is one of the few recurring patterns described across published cases.
Doctors believe an inflammatory process inside the eye is a key biological factor in persistent placoid maculopathy. In many people, this inflammation seems to affect the tissues under the retina that support clear central vision.
Reduced circulation in the thin blood vessel layer beneath the retina is thought to play an important role. This may help explain why the condition creates flat, pale lesions in the macular area.
Some similar placoid eye conditions have appeared after a viral-like illness or another infection. For persistent placoid maculopathy, this is still considered a possible trigger rather than a proven risk factor.
Genetic risk factors
Persistent placoid maculopathy does not currently have a known genetic cause. For people wondering whether persistent placoid maculopathy is hereditary, research has not shown a clear family pattern or a confirmed disease gene. Science continues to uncover how these elements interact, but at this stage genetic testing is not a standard way to predict risk.
No single gene: No gene has been proven to directly cause persistent placoid maculopathy. Most reported cases appear sporadically, meaning they happen without a known inherited mutation.
Family history: Doctors have not identified a consistent pattern of this condition running in families. That means relatives are not currently known to have a clearly increased inherited risk.
Immune gene links: Researchers suspect genes that affect immune and inflammatory responses may play a part in some people. So far, though, no specific immune-related gene change has been confirmed as a reliable risk factor.
Lifestyle risk factors
There are no well-established lifestyle habits known to directly cause persistent placoid maculopathy. However, some everyday behaviors may influence retinal circulation, inflammation, recovery, and how well treatment plans are followed. When people ask about lifestyle risk factors for persistent placoid maculopathy, the main concern is usually factors that could worsen eye health or complicate management rather than trigger the disease itself.
Smoking can impair blood flow and increase oxidative stress in delicate retinal tissues. This may place extra strain on the macula and can work against overall eye health during an active or recovering phase.
A diet low in fruits, vegetables, and omega-3-rich foods may offer less support against oxidative stress and inflammation. Poor dietary patterns can also worsen vascular health, which is relevant because the retina depends on a steady blood supply.
Low activity levels can contribute to poorer cardiovascular and metabolic health over time. Reduced vascular fitness may indirectly affect retinal health and overall recovery capacity.
Chronic poor sleep can promote systemic inflammation and make visual symptoms harder to cope with. Fatigue may also reduce adherence to medications, follow-up visits, and symptom monitoring.
Risk prevention
There is no known, proven way to fully prevent persistent placoid maculopathy because its exact cause is not well understood. In practice, prevention is mostly about lowering the risk of lasting vision problems through early diagnosis, careful follow-up, and treatment when needed. Prevention is about lowering risk, not eliminating it completely. If you notice new blurry patches, dim areas, or changes near the center of vision, getting urgent eye care can make a real difference.
There is no routine step known to stop persistent placoid maculopathy from starting, but early care may help limit damage. Sudden blurry central vision, gray spots, or trouble reading are reasons to seek prompt evaluation, especially if early symptoms of persistent placoid maculopathy appear over days to weeks.
Regular visits with an eye specialist help track whether the retinal spots are settling or becoming active again. These exams also help catch complications early, before vision changes become more severe.
If your specialist prescribes medicine to calm inflammation or protect vision, taking it as directed can lower the chance of ongoing injury. Stopping treatment on your own or missing follow-up can make it harder to spot problems in time.
Some people with persistent placoid maculopathy can develop abnormal blood vessels under the retina, which may leak or bleed. Ongoing monitoring helps find this early, when treatment is often more effective.
Can you prevent Persistent placoid maculopathy?
No, there is no proven way to prevent persistent placoid maculopathy at this time. This rare condition affects the center of the back of the eye, and its exact cause is still not well understood, so it has not been clearly tied to lifestyle habits that people can change. Getting urgent eye care for new blurry central vision or a new dark spot cannot stop it from starting, but it may help protect vision by catching it early.
Transmission
Persistent placoid maculopathy is not considered contagious, so it does not spread from one person to another through touching, coughing, kissing, sex, blood, or sharing food. Many people wonder whether persistent placoid maculopathy can be caught from someone else, but current evidence does not support that.
It is also not usually described as an inherited condition passed from parent to child. For most people living with persistent placoid maculopathy, the condition appears to happen sporadically, and doctors think it is more likely related to inflammation in the back of the eye than to any form of infectious transmission.
When to test your genes
For persistent placoid maculopathy, genetic testing is not routinely recommended because this condition is not known to be driven by a single inherited gene. Early detection and personalized care rely much more on prompt retinal evaluation, imaging, and follow-up with an eye specialist.
Diagnosis
Persistent placoid maculopathy is usually diagnosed after a person develops blurred central vision, dim spots, or trouble reading and an eye specialist sees characteristic changes at the back of the eye. Because these symptoms can overlap with other retinal and inflammatory conditions, the diagnosis of persistent placoid maculopathy often relies on combining the exam with several eye imaging tests. It’s natural to worry when symptoms don’t have a clear explanation.
The eye doctor asks when vision changes started, whether one or both eyes are affected, and if there are flashes, blind spots, or color changes. This helps connect day-to-day symptoms with a retinal problem and guides the next tests.
After using drops to widen the pupil, the doctor looks closely at the retina and macula. People with persistent placoid maculopathy often have flat, pale plaque-like areas that help point toward the diagnosis.
Color fundus photographs document the appearance and location of the lesions. These images also help track whether the spots are stable, improving, or spreading over time.
Optical coherence tomography, often called OCT, uses light waves to create detailed cross-section images of the retina. It can show damage or swelling in the light-sensing layers and helps monitor how much the macula is involved.
How is Persistent placoid maculopathy diagnosed?
Persistent placoid maculopathy is usually diagnosed by an eye specialist based on changes in central vision, a dilated eye exam, and detailed pictures and scans of the retina, the light-sensitive layer at the back of the eye. These tests may include light-based scans and sometimes a dye test to look for the flat pale patches and check blood flow under the retina, which helps rule out other eye problems that can look similar. Genetic testing is not usually part of the diagnosis.
Stages of Persistent placoid maculopathy
Persistent placoid maculopathy does not have defined progression stages. This is because it is usually described by changes seen in the retina during active periods and follow-up, rather than a well-established step-by-step pattern that everyone moves through over time. Doctors usually start with a conversation about changes in vision, such as blurred central vision, dim spots, or trouble reading, which can overlap with early symptoms of persistent placoid maculopathy. Diagnosis and monitoring usually rely on eye examination, retinal imaging, and sometimes tests that show blood flow or inflammation in the back of the eye to track whether the condition is active, stable, or causing lasting damage.
Outlook and prognosis
The outlook for persistent placoid maculopathy is variable, but many patients face a chronic or relapsing course with a risk of permanent central vision loss if the macula remains affected. Some people improve with prompt treatment, especially systemic corticosteroids and sometimes longer-term immunomodulatory therapy, while others continue to show progression or recurrence despite treatment. Visual prognosis is generally worse when there is extensive damage to the retinal pigment epithelium and outer retina, because these changes can leave lasting blind spots or reduced reading vision. Close follow-up is important, since recurrent inflammation can further impair vision even after an initial response. Persistent placoid maculopathy is not generally considered life-threatening, and there is no known increase in mortality directly caused by the eye disease itself.
Long-term effects
For many, persistent placoid maculopathy can leave lasting changes in central vision, especially if the macula has been inflamed for a long time. Day to day, this may mean faces look less clear, print is harder to read, or straight lines seem a little distorted even after the active phase settles. It’s important to remember that long-term doesn’t always mean progressive, but some people do have ongoing or repeated damage that affects sight over time.
The most important long-term effect is reduced sharp central vision, which can make reading, driving, and detailed work harder. Some people improve partly, but others are left with a permanent blurry or dim spot in the center of sight.
Persistent placoid maculopathy can cause lasting scotomas, meaning patches of missing or faded vision. You might notice this when a word seems to have letters missing or part of a face disappears when you look straight at it.
Straight lines may look bent, uneven, or broken if the central retina has been damaged. After the early symptoms of persistent placoid maculopathy, this distortion can remain even when redness or active inflammation is no longer obvious.
Over time, inflammation can leave thinning, scarring, or atrophy in the light-sensing layers at the back of the eye. These structural changes often explain why vision does not fully return to normal.
How is it to live with Persistent placoid maculopathy?
Living with persistent placoid maculopathy often means coping with changes in central vision, such as blurred spots, dim areas, or trouble seeing fine detail, which can make reading, driving, screen use, and recognizing faces much harder. For many people, symptoms can fluctuate or affect both eyes over time, so daily life may require more frequent eye appointments, extra lighting, larger print, and help with tasks that depend on sharp vision. This can also affect family and coworkers, who may need to adjust expectations, offer practical support, or help with transportation, but with low-vision strategies and close follow-up, many living with this condition find ways to stay independent and connected.
Treatment and drugs
Persistent placoid maculopathy is usually treated by an eye specialist with the goal of calming inflammation quickly and protecting central vision. Treatment often starts with steroid medicine, given as pills, injections, or sometimes through a vein, and some people need longer-term medicines that quiet the immune system if the disease keeps coming back or does not fully settle. Not every treatment works the same way for every person, so follow-up visits with eye scans are an important part of care to check whether the retina is healing or if treatment needs to change. If doctors suspect a related infection or another inflammatory condition elsewhere in the body, that problem also needs to be treated. Because early treatment can matter, people worried about early symptoms of Persistent placoid maculopathy should seek urgent eye care, especially if they notice a new blurry spot or distortion in the center of vision.
Can you cure Persistent placoid maculopathy?
No, there is no known cure for persistent placoid maculopathy at this time. Treatment aims to calm the inflammation in the back of the eye and help protect vision, often with steroid medicines or other drugs that quiet an overactive immune response. Many living with this condition need close follow-up, because vision may improve with treatment but can still change over time.
Non-drug treatment
Persistent placoid maculopathy can make reading, driving, or recognizing faces suddenly much harder, so day-to-day support matters even while eye specialists treat the underlying inflammation. Beyond prescriptions, supportive therapies can help protect safety, reduce visual strain, and make the most of the vision you still have. Because this condition is rare and can change quickly, non-drug care is usually used alongside close follow-up rather than instead of medical treatment. If you are looking into non-drug treatment for persistent placoid maculopathy, the main options focus on monitoring, vision rehabilitation, and practical adjustments at home or work.
Regular visits with a retina specialist help track whether the affected areas are stable, improving, or spreading. Eye scans and visual testing can catch changes early, sometimes even before you notice a clear shift in sight.
Low vision services teach practical ways to use remaining sight more effectively for reading, cooking, work, and getting around. This may include training in lighting, contrast, and viewing techniques that reduce frustration in daily tasks.
Magnifiers, large-print devices, screen readers, and electronic reading tools can make central vision problems easier to work around. Many people with persistent placoid maculopathy find these tools most helpful when they are fitted to specific tasks, such as reading bills or using a phone.
Brighter lighting, glare control, high-contrast labels, and decluttering walkways can make everyday activities safer and less tiring. Some strategies can slip naturally into your routine—like better task lighting at a desk or larger text settings on digital devices.
Your genes may have an impact on how drugs work for you
For people living with persistent placoid maculopathy, treatment often centers on medicines that calm inflammation, such as steroids and sometimes other immune-calming drugs, and small differences in a person’s genes can affect how strongly these medicines work or how likely side effects may be. In everyday life, that can mean one person’s eye inflammation settles quickly while another may need a different dose, closer follow-up, or a switch to another treatment because of problems like mood changes, blood sugar changes, or trouble tolerating the medicine. Even so, genetic testing is not a routine part of care for this eye condition right now, and doctors usually choose treatment based more on symptoms, eye exam findings, and how someone responds over time.
Pharmacological treatments
Treatment for persistent placoid maculopathy is aimed at calming inflammation quickly to protect central vision, especially when reading, driving, or recognizing faces becomes harder. The drugs most often used are corticosteroids first, followed by longer-term immune-lowering medicines if the disease is persistent or comes back. Not everyone responds to the same medication in the same way. Because this condition is rare, treatment is usually tailored by an eye inflammation specialist.
Oral prednisone is often the first medicine used because it can reduce retinal inflammation relatively quickly. In people with early symptoms of persistent placoid maculopathy, doctors may use it promptly to try to limit further damage to the macula.
Methylprednisolone given by vein may be used when vision is dropping quickly or the inflammation is severe. This is usually a short, high-dose treatment, followed by steroid tablets such as prednisone.
Mycophenolate mofetil, azathioprine, and methotrexate are commonly used when steroids alone are not enough or would be risky long term. These medicines work more slowly, so they are often started while steroids are being tapered.
Cyclosporine or tacrolimus may be used to further suppress the immune attack in stubborn cases of persistent placoid maculopathy. Dosing may be increased or lowered gradually to balance inflammation control with side effects.
Genetic influences
Persistent placoid maculopathy is not currently known to be a clearly inherited eye disease, and researchers have not linked it to one specific gene change. It’s natural to ask whether family history plays a role. So far, most cases seem to happen sporadically, without a clear pattern of persistent placoid maculopathy running in families. Doctors think this condition is more closely tied to inflammation and changes in the blood-supply layer under the retina, so if genetics play a part, it is likely to be indirect and still not well defined. Because the genetic causes of persistent placoid maculopathy have not been clearly identified, genetic testing is not usually part of routine care, though your eye specialist may still ask about family history to help rule out other retinal problems that can look similar.
Is Persistent placoid maculopathy genetic?
Genetics do not appear to play a major role in Persistent placoid maculopathy. Most cases are not thought to be inherited, and no specific gene changes are known to clearly cause it.
Having a genetic risk is not necessarily a diagnosis
It is normal for people to have genetic variants, and these are common across the general population. Most of these variants do not directly affect health and simply reflect natural human diversity. In many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, particularly when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm the diagnosis.
Pharmacogenetics—how genetics influence drug effects
When central vision stays blurry or a gray spot makes reading hard, treatment for persistent placoid maculopathy is usually guided by eye exams and retinal scans rather than by a genetic result. At present, there are no well-established genetic tests that routinely tell doctors which medicine will work best for persistent placoid maculopathy. Some inherited differences can affect how the body handles medicines often used to calm eye inflammation, such as corticosteroids or other immune-suppressing drugs, so side effects or dose needs may vary from one person to another. Not every difference in response is genetic, but other medicines, liver function, and the overall cause and severity of the inflammation also matter. If you are asking about genetic testing for persistent placoid maculopathy treatment, it is not yet a standard part of care. For many living with persistent placoid maculopathy, doctors personalize treatment mainly through careful follow-up and by adjusting medicines if vision changes, inflammation returns, or side effects develop.
Interactions with other conditions
Persistent placoid maculopathy can sometimes appear alongside other inflammatory eye disorders, so doctors often look carefully for signs that another retinal or choroidal condition is also present. Another important aspect is how it may link with other diseases. In practice, this usually means ruling out infections and whole-body inflammatory illnesses that can cause similar changes in the back of the eye, because treatment may differ if another disease is driving the problem. For many living with persistent placoid maculopathy, that workup can include checking for conditions such as syphilis, tuberculosis, or sarcoidosis, as well as autoimmune disorders when the eye findings or medical history suggest them. This matters because some of the early symptoms of persistent placoid maculopathy, such as blurred or distorted central vision, can overlap with symptoms from these other conditions, making diagnosis less straightforward. If another disease is present, care is often coordinated between an eye specialist and other doctors so treatment targets both vision and the underlying cause.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
What other conditions can cause similar symptoms to Persistent placoid maculopathy?
Similar symptoms can happen with central serous retinopathy, age-related macular degeneration, and other inflammatory problems at the back of the eye, all of which can cause blurry central vision, dim spots, or trouble reading. Some infections, especially syphilis, can also look very similar, so an eye specialist often needs scans and sometimes blood tests to tell them apart.
History
People living with persistent placoid maculopathy often reach the name only after several eye visits, because its early changes can look like other problems that affect the center of vision. The condition entered the medical literature relatively recently, when retina specialists began reporting people with broad, flat, pale lesions in the macula that lasted much longer than expected and did not fit neatly into better-known inflammatory eye disorders.
At first, these cases were mainly recognized by what doctors could see during an eye exam and on retinal photographs. Initially understood only through symptoms, later it became clearer that persistent placoid maculopathy had its own pattern: blurred central vision, trouble reading, and lasting placoid changes in the retina rather than the quicker recovery often seen in some related conditions.
As imaging tools improved, the history of persistent placoid maculopathy became easier to trace. Tests that show the retina in cross-section and studies of blood flow in the layers under the retina helped doctors see that this was not just a variation of another disease, but a distinct condition with a characteristic course.
This better understanding matters in everyday life. Someone may notice that straight lines look washed out, print seems dim or patchy, or one eye is not as sharp as it was a few weeks earlier. Reports over time showed that these early symptoms of persistent placoid maculopathy could persist and sometimes progress, which is one reason the condition drew more attention in retina clinics.
Because persistent placoid maculopathy is uncommon, much of its history has come from small case series and careful follow-up rather than large studies. Even so, those reports have helped shape today’s approach by showing how the condition tends to behave, how it can resemble other inflammatory diseases of the retina, and why close monitoring is important when vision changes do not quickly settle.